These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 321029)

  • 21. phiX174 DNA-dependent DNA synthesis in vitro: requirement for P1 ban protein in dnaB mutant extracts of Escherichia coli.
    Schuster H; Mikolajczyk M; Rohrschneider J; Geschke B
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):3907-11. PubMed ID: 670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage phi X174 DNA synthesis in Escherichia coli HF4704S (dnaHts) cells.
    Sakai H; Komano T
    Biochim Biophys Acta; 1975 Jul; 395(4):433-45. PubMed ID: 1096950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterologous transfection with bacteriophage phiX174 DNA. Unusual heterogeneous products.
    Suzuki M; Azegami M
    Biochim Biophys Acta; 1977 Feb; 474(4):646-61. PubMed ID: 402155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of the rep protein of Escherichia coli. An ATPase which separates duplex DNA strands in advance of replication.
    Scott JF; Kornberg A
    J Biol Chem; 1978 May; 253(9):3292-7. PubMed ID: 147873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of phiX174 DNA-dependent ATPase activity with an Escherichia coli protein, replication factor Y, required for in vitro synthesis of phiX174 DNA.
    Wickner S; Hurwitz J
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3342-6. PubMed ID: 127175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymatic synthesis of duplex circular phiX174 DNA containing phosphoramidate bonds in the (-) strand.
    Letsinger RL; Hapke B; Petersen GR; Dumas LB
    Nucleic Acids Res; 1976 Apr; 3(4):1053-63. PubMed ID: 775443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two new genetic assays for noninfectious fragments of phiX174 DNA.
    Dodgson JB; Nes IF; Porter BW; Wells RD
    Virology; 1976 Feb; 69(2):782-5. PubMed ID: 769307
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA replication in vitro starting with an intact phiX174 phage.
    Jazwinski SM; Kornberg A
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):3863-7. PubMed ID: 1105565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage phiX174 growth in an Escherichia coli dnaIts mutant, KS810.
    Sakai H; Watabe K; Komano T
    Biochim Biophys Acta; 1978 Feb; 517(2):531-4. PubMed ID: 341986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro transcription units of bacteriophage phiX174. II. In vitro initiation sites of phiX174 transcription.
    Smith LH; Sinsheimer RL
    J Mol Biol; 1976 Jun; 103(4):699-710. PubMed ID: 781283
    [No Abstract]   [Full Text] [Related]  

  • 31. Formation of the parental replicative form of bacteriophage phiX174.
    Zuccarelli AL; Benbow RM; Sinsheimer RL
    J Mol Biol; 1976 Sep; 106(2):375-402. PubMed ID: 1086367
    [No Abstract]   [Full Text] [Related]  

  • 32. Inactivation of the T7 coliphage by monofunctional alkylating agents. Action of phage adsorption and injection of its DNA.
    Karska-Wysocki B; Thibodeau L; Verly WG
    Biochim Biophys Acta; 1976 Jun; 435(2):184-91. PubMed ID: 181068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lipopolysaccharide receptor for bacteriophage phiX174 and S13.
    Jazwinski SM; Lindberg AA; Kornberg A
    Virology; 1975 Jul; 66(1):268-82. PubMed ID: 1094681
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective inhibition of in vitro DNA synthesis dependent on phiX174 compared with fd DNA. I. Protein requirements for selective inhibition.
    Vicuna R; Hurwitz J; Wallace S; Girard M
    J Biol Chem; 1977 Apr; 252(8):2524-33. PubMed ID: 140166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative reactivities of diolepoxide metabolites of carcinogenic hydrocarbons with phiX174 viral DNA.
    Hsu WT; Lin EJ; Fu PP; Harvey RG; Weiss SB
    Biochem Biophys Res Commun; 1979 May; 88(1):251-7. PubMed ID: 378230
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of rifampicin on the infectivity of RNA bacteriophage f2.
    Naimski P; Chroboczek J
    Eur J Biochem; 1977 Jun; 76(2):419-23. PubMed ID: 330161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo production of an RNA-DNA copolymer after infection of Escherichia coli by bacteriophage T4.
    Buckley PJ; Kosturko LD; Kozinski AW
    Proc Natl Acad Sci U S A; 1972 Nov; 69(11):3165-9. PubMed ID: 4564205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in vitro transcription units of bacteriophage phiX174. I. Characterization of synthetic parameters and measurement of transcript molecular weights.
    Smith LH; Sinsheimer RL
    J Mol Biol; 1976 Jun; 103(4):681-97. PubMed ID: 781282
    [No Abstract]   [Full Text] [Related]  

  • 39. The gene H spike protein of bacteriophages phiX174 and S13. I. Functions in phage-receptor recognition and in transfection.
    Jazwinski SM; Lindberg AA; Kornberg A
    Virology; 1975 Jul; 66(1):283-93. PubMed ID: 1094682
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapid inactivation of bacteriophage T7 by ascorbic acid is repairable.
    Richter HE; Loewen PC
    Biochim Biophys Acta; 1982 Apr; 697(1):25-30. PubMed ID: 7044421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.